AI Portfolio Summary
In 2025 Q4, Matrix Capital Management Company, LP maintained a portfolio of 3 distinct positions. Conversely, Matrix Capital Management Company, LP completely exited their position in ZENTALIS PHARMACEUTI.
Total Positions
3
Quarter
2025 Q4
Top Holding
AURA (65.5%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-3 of 3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 65.48% | 40.08% |
#1
1
Prev: #2
|
10.0 | no change | no change |
P
S
|
6,922,870 | $37,729,642 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 34.52% | 40.17% |
#2
1
Prev: #1
|
10.0 | -1,173,684 | -71.0% |
P
S
|
480,000 | $19,886,400 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 0.00% | 19.75% |
Sold All 😨
(Was: #3) |
0.3 | -13,959,973 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-3 of 3 holdings